Jeffrey Harris
Corporate Officer/Principal chez University of California San Diego
Postes actifs de Jeffrey Harris
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| University of California San Diego | Corporate Officer/Principal | 07/09/2009 | - |
| Collegium Oto-Rhino-Laryngologicum Amicitiae Sacrum | Corporate Officer/Principal | 07/09/2009 | - |
Historique de carrière de Jeffrey Harris
Anciens postes connus de Jeffrey Harris
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| American Otological Society, Inc. | President | - | - |
| The Association for Research in Otolaryngology | President | - | - |
| OTONOMY | Directeur/Membre du Conseil | 07/09/2009 | - |
| Fondateur | 01/04/2008 | - |
Formation de Jeffrey Harris
| University of Pennsylvania | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
| France | 2 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| President | 2 |
| Director/Board Member | 1 |
Sectorielle
| Consumer Services | 3 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Otonomy, Inc.
 Otonomy, Inc. BiotechnologyHealth Technology Otonomy, Inc. operates as a biopharmaceutical company. engages in the development of therapeutics for neurotology. The firm’s product pipeline includes OTIVIDEX (dexamethasone) Meniere's disease, OTIPRIO (ciprofloxacin otic suspension) acute otitis media with tubes (AOMT), OTO-313 (gacyclidine) tinnitus, OTO-413 (BDNF) hidden hearing Loss, OTO-510 (otoprotectant) prevent CIHL, OTO-6XX (hair cell regeneration) severe hearing loss. It operates under the Otiprio brand. The company was founded by Jay B. Lichter, Jeffrey Harris, Rick Friedman, and Allen F. Ryan on May 6, 2008 and is headquartered in San Diego, CA. | Health Technology |
| American Otological Society, Inc. | |
| The Association for Research in Otolaryngology | |
| Collegium Oto-Rhino-Laryngologicum Amicitiae Sacrum |
- Bourse
- Insiders
- Jeffrey Harris
- Expérience
